TransEnterix Announces Approval of Senhance® Surgical System in Russian Federation
TransEnterix Announces Approval of Senhance® Surgical System in Russian Federation TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Senhance Surgical System has received its registration certificate by Roszdravnadzor, the Russian medical device regulatory agency allowing for its sale and utilization throughout the Russian Federation. Russian regulatory approval is an important milestone for TransEnterix, and this is an underserved market for robotic surgery, said Anthony Fernando, President and Chief Executive Officer of TransEnterix. Russia has rapidly developed expertise and adoption of minimally invasive surgery over the past 10 years, but robotic surgery remains extremely limited in the region due to high per-procedure costs and the success
Posted on 505
TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Southern Surgical Hospital has entered into an agreement to lease and utilize a Senhance
® Surgical System.
“We are pleased to support Southern Surgical Hospital in advancing care with the addition of the Senhance Surgical System,” said Anthony Fernando, President and Chief Executive Officer at TransEnterix. “Hospitals throughout the world, and the US, remain interested in advancing minimally invasive surgery with digital assistance while managing health care costs and resources. This Senhance digital laparoscopic program will be a good complement to their outpatient minimally invasive surgical care initiatives for their surgeons and patients.
Share:
Represents the Third Senhance Surgical Program Initiated in Louisiana
TransEnterix, Inc. (NYSE:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Southern Surgical Hospital has entered into an agreement to lease and utilize a Senhance
® Surgical System. We are pleased to support Southern Surgical Hospital in advancing care with the addition of the Senhance Surgical System, said Anthony Fernando, President and Chief Executive Officer at TransEnterix. Hospitals throughout the world, and the US, remain interested in advancing minimally invasive surgery with digital assistance while managing health care costs and resources. This Senhance digital laparoscopic program will be a good complement to their outpatient minimally invasive surgical care initiatives for their surgeons and patients.
TransEnterix Announces Southern Surgical Hospital to Initiate a Senhance® Digital Laparoscopic Program - Press Release digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.
Posted on 213
TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Senhance
® Surgical System has received its registration certificate by Roszdravnadzor, the Russian medical device regulatory agency allowing for its sale and utilization throughout the Russian Federation.
“Russian regulatory approval is an important milestone for TransEnterix, and this is an underserved market for robotic surgery,” said Anthony Fernando, President and Chief Executive Officer of TransEnterix. “Russia has rapidly developed expertise and adoption of minimally invasive surgery over the past 10 years, but robotic surgery remains extremely limited in the region due to high per-procedure costs and the success of laparoscopic approaches. Senhance helps address these adoption hurdles. We have w